Revenue from Contract with Customer, Excluding Assessed Tax of Iterum Therapeutics plc from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Iterum Therapeutics plc quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Iterum Therapeutics plc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $390,000.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $0.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $0, a 100% decline from 2019.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2019 was $37,000, a 96% decline from 2018.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

Iterum Therapeutics plc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $390,000 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2019 $715,000 $37,000 -$154,000 -81% 01 Jan 2019 31 Mar 2019 10-K 12 Mar 2021 2020 FY
Q4 2018 $869,000 $239,000 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $254,000 +$95,000 +60% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020 2019 FY
Q2 2018 $185,000 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020 2019 FY
Q1 2018 $191,000 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020 2019 FY
Q3 2017 $159,000 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3

Iterum Therapeutics plc Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2022 2021 FY
2020 $0 -$37,000 -100% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $37,000 -$832,000 -96% 01 Jan 2019 31 Dec 2019 10-K 28 Mar 2022 2021 FY
2018 $869,000 +$361,000 +71% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021 2020 FY
2017 $508,000 +$508,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2016 $0 01 Jan 2016 31 Dec 2016 10-K 25 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.